MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - a randomized, double-blind, placebo-controlled, phase 3 study

被引：0

作者：

Janjigian, Yelena ^{[1
]}

Van Cutsem, Eric ^{[2
,3
]}

Muro, Kei ^{[4
]}

Wainberg, Zev ^{[5
]}

Al-Batran, Salah-Eddin ^{[6
]}

Hyung, Woo Jin ^{[7
]}

Molena, Daniela ^{[8
]}

Evans, Brent ^{[9
]}

Ruscica, Dario ^{[10
]}

Robbins, Scott H. ^{[9
]}

Negro, Alejandra ^{[9
]}

Tabernero, Josep ^{[11
]}

机构：

[1] Mem Sloan Kettering, New York, NY USA

[2] Univ Hosp Leuven, Leuven, Belgium

[3] KULeuven, Leuven, Belgium

[4] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[5] UCLA, David Geffen Sch Med, Los Angeles, CA USA

[6] Univ Canc Ctr, Frankfurt, Germany

[7] Yonsei Univ, Coll Med, Seoul, South Korea

[8] Mem Sloan Kettering, New York, NY USA

[9] AstraZeneca, Gaithersburg, MD USA

[10] AstraZeneca, Cambridge, England

[11] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1044

引用

页码：94 / 94

页数：1

共 50 条

[21] KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction cancer (mG/GEJC): A double-blind, randomized, placebo-controlled phase 3 study.
Janjigian, Yelena Yuriy
Bang, Yung-Jue
Fuchs, Charles S.
Qin, Shukui
Satoh, Taroh
Shitara, Kohei
Tabernero, Josep
Van Cutsem, Eric
Cao, Z. Alexander
Chen, Xinqun
Kang, S. Peter
Shih, Chie-Schin
Chung, Hyun Cheol
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[22] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
Guntupalli, Kalpalatha
Dean, Nathan
Morris, Peter E.
Bandi, Venkata
Margolis, Benjamin
Rivers, Emanuel
Levy, Mitchell
Lodato, Robert F.
Ismail, Preeti M.
Reese, Amber
Schaumberg, John P.
Malik, Rajesh
Dellinger, R. Phillip
CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
[23] Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study
Earley, Willie R.
Burgess, Maria V.
Khan, Barbara
Rekeda, Ludmyla
Suppes, Trisha
Tohen, Mauricio
Calabrese, Joseph R.
BIPOLAR DISORDERS, 2020, 22 (04) : 372 - 384
[24] Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double-blind, placebo-controlled, Phase 2 study
King, B.
Mesinkovska, N.
Senna, M.
Luo, X.
Minkiewicz, J.
Selfridge, A.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
[25] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Busse, W. W.
Wenzel, S. E.
Meltzer, E. O.
Kerwin, E. M.
Liu, M. C.
Zhang, N.
Chon, Y.
Lin, J.
Lin, S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
[26] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
McDonald, C.
Wu, S.
Gulati, S.
Komaki, H.
Ruiz-Garcia, M.
Kostera-Pruszczyk, A.
Vlodavets, D.
Chae, J.
Jong, Y.
Karachunski, P.
Statland, J.
Lorentzos, M.
Penematsa, V
Chou, C.
Lin, M.
Werner, C.
Trifillis, P.
Gordon, G.
Klein, M.
NEUROMUSCULAR DISORDERS, 2022, 32
[27] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
Croop, R.
Lipton, R. B.
Kudrow, D.
Stock, D. A.
Kamen, L.
Conway, C. M.
Stock, E. G.
Coric, V.
Goadsby, P. J.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
[28] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine
Croop, R.
Lipton, R. B.
Kudrow, D.
Stock, D. A.
Kamen, L.
Conway, C. M.
Stock, E. G.
Coric, V
Goadsby, P. J.
HEADACHE, 2021, 61 : 98 - 99
[29] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)
Tarantino, Michael D.
Bussel, James B.
Blanchette, Victor S.
Despotovic, Jenny
Bennett, Carolyn
Raj, Ashok
Williams, Bronwyn
Beam, Donald
Morales, Jaime
Rose, Melissa J.
Carpenter, Nancy
Nie, Kun
Eisen, Melissa
BLOOD, 2015, 126 (23)
[30] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
McDonald, Craig M.
Wu, Shiwen
Gulati, Sheffali
Komaki, Hirofumi
Escobar, Rosa E.
Kostera-Pruszczyk, Anna
Vlodavets, Dmitry
Chae, Jong-Hee
Jong, Yuh-Jyh
Karachunski, Peter
Statland, Jeffrey
Lorentzos, Michelle
Penematsa, Vinay
Chou, Connie
Lin, Min
Werner, Christian
Trifillis, Panayiota
Gordon, Gregory
Koladicz, Karyn
Mastrandrea, Nicholas
Klein, Matthew
NEUROLOGY, 2023, 100 (17)

← 1 2 3 4 5 →